• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Stock

Is it safe to buy the Tempus AI stock dip now?

by April 9, 2025
by April 9, 2025

Tempus AI stock price remains in a deep bear market as investors worry that the hype that drove it to a record high was ending. The TEM stock initially peaked at $91.40 in February, and has now plunged to a low of $37.2, meaning that it has dropped by 60%. So, is it safe to buy the dip or wait for it to fall further?

Why Tempus AI has plunged

Tempus AI is one of the top American companies in the artificial intelligence space. Its goal is to help all players in the medical industry to simplify their operations, boost innovation, reduce costs, and grow sales. 

The Tempus Platform comprises three key components, including Tempus Hub, Tempus Lens, and Tempus Lens. Tempus Hub is a platform that streamlines providers’ workflows and gives access to patient insights. 

Lens is a platform that helps researchers to find, access, and analyze multimodal data and uncover crucial insights. Next is a tool that helps providers deliver the next steps in a patient’s care data. 

Analysts believe that the medical industry is one of the best use cases for the artificial intelligence industry. It is primarily useful in research since large AI models can analyze vast data within minutes. 

AI technology is also useful in areas like diagnostics and treatment. It generates results like DNA, RNA, clinical imaging, clinical EMR, and epigenetics. 

Tempus AI business has grown rapidly in the past few years as more companies have embraced its technology. It is now used by some of the top companies in the healthcare industry like AstraZeneca, GlaxoSmithKline, BioNTech, Rain Oncology, and Kronos Bio.

TEM business is growing

The most recent results showed that Tempus AI business was growing. Its quarterly revenue rose by 35.8% YoY in the last quarter of 2024 to $200.7 million. Most of this revenue came from its genomics segment, which made over $120.4 million. The data and services segment rose to $80.2 million.

Most importantly, the company is making more strides to become profitable. Its gross profit rose by almost 50% to $122.1 million, while the net loss improved to $13 million, up from $50 million a quarter earlier. 

The annual revenue jumped by 30% to $693 million, with its genomics business making over $451.7 million. The data and service segment rose to $241 million.

Analysts are optimistic that the Tempus AI business will continue doing well this year. The average estimate is that its first quarter revenue will be $248.8 million. Its annual revenue will be $1.24 billion, followed by $1.55 billion next year. The company will break even next year. 

Analysts are highly bullish on the TEM stock, with the average estimate being $64.22, higher than the current $37.23.

Read more: Cathie Wood bets big on Tempus AI: Is it the next big thing in health-tech?

Tempus AI stock price analysis

TEM stock chart | Source: TradingView

The daily chart shows that the TEM share price has crashed in the past few weeks, moving from the year-to-date high of $91.40 to a low of $37.23. This price is along the ascending trendline that connects the lowest swing since June last year. 

The stock has moved below the 25-day moving average. It has also moved slightly below the bottom of the trading range at $37.5. The Relative Strength Index (RSI) also dropped below the middle line at 50.

Therefore, the stock will likely continue falling as sellers target the key target at $25, the strong pivot, and reverse at $25. In the future, however, Tempus AI stock price will likely bounce back, and possibly retest its all-time high.

The post Is it safe to buy the Tempus AI stock dip now? appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Why analysts are betting on Richemont and Hermes stocks as Trump tariffs take sheen off the luxury sector
next post
Nio stock price resilient to trade war, yet crash to $1.12 likely

Related Posts

Analysis: Crude prices under pressure as 2026 outlook...

October 6, 2025

Tata Capital eyes $15.7 billion valuation in India’s...

October 6, 2025

India may settle $22.5bn Vodafone dispute to cement...

October 6, 2025

Here’s why the Rolls-Royce share price is up...

October 6, 2025

Ardian buys Ireland’s Energia Group in €2.5bn deal...

October 6, 2025

Europe markets open: Stoxx 600 slips 0.1% as...

October 6, 2025

China Financial Leasing’s $11M plan signals Hong Kong’s...

October 6, 2025

Japanese stocks may extend record run as Takaichi...

October 5, 2025

Former Tesla exec sees continued growth for EVs;...

October 5, 2025

Weekly wrap: A US shutdown; a UK terror...

October 5, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • CommsCloud’s new SIMs make borderless African IoT logistics a reality

    October 6, 2025
  • Housing’s Deep Freeze: Existing Home Sales at 25-Year Lows

    October 6, 2025
  • Nigeria’s Shea Ban Backfires, Crushing Millions of Women Workers

    October 6, 2025
  • Analysis: Crude prices under pressure as 2026 outlook signals surplus

    October 6, 2025
  • Tata Capital eyes $15.7 billion valuation in India’s biggest IPO of 2025

    October 6, 2025
  • India may settle $22.5bn Vodafone dispute to cement UK ties

    October 6, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 5

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 6

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 7

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025

Categories

  • Economy (2,791)
  • Editor's Pick (280)
  • Investing (185)
  • Stock (1,904)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Top 3 catalysts for the VOO ETF...

July 27, 2025

UnitedHealth stock price forms two patterns, pointing...

July 3, 2025

Forever 21 files for bankruptcy in the...

March 17, 2025